TENLIPTIN
TENELIGLIPTIN · by INDUS PHARMA
Composition
Tab 20 mg: Teneligptin 20 mg
Indications & Dosage
Type 2 diabetes mellitus as monotherapy or in combination with insulin (with or without metformin) to achieve adequate glycaemic control: Adult: 20 mg once daily, dose may be increase up to 40 mg once daily if required. Dose of concomitant sulfonylurea or insulin may need to be reduced.
Contraindications
Ketoacidosis, severe heart failure, severe hepatic impairment, diabetic coma, type 1 diabetes, patient with severe infection, surgery or trauma
Precautions
Cardiac disorders, renal impairment, hepatic impairment, monitor liver function before treatment and every 3 months for first year and periodically thereafter, elderly, pituitary/adrenal insufficiency.
Pregnancy
Contraindicated in pregnancy
Lactation
Contraindicated or not recommended.
Side Effects
Peripheral oedema, lactic acidosis (discontinue), asthenia, dizziness, headache, tremor, arthralgia, constipation, hypoglycaemia, Rare: Hepatic dysfunction, upper respiratory tract infection, nasopharyngitis, exfoliative skin reactions and pancreatitis (discontinue).